Mark Christopher Capone - 18 Jul 2022 Form 4 Insider Report for DermTech, Inc.

Role: Director
Signature: /s/ Jason S. Miller, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 18 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 20 Jul 2022, 20:12:48 UTC
Next filing: 05 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DMTK	Common Stock	Award	$0	+26,480		$0.000000	26,480	18 Jul 2022	Direct	F1
transaction	DMTK	Common Stock	Award	$0	+19,860	+75%	$0.000000	46,340	18 Jul 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in three equal annual installments over the three-year period following the grant date, subject to the reporting person's continued service.
F2	The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in one installment on May 26, 2023.

Content

The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in three equal annual installments over the three-year period following the grant date, subject to the reporting person's continued service.